MENU

MA2 Molecular Glue: MDA5 Agonist for Innate Immunity Stimulation

bioRxiv USA
Overview
Researchers have identified MA2, a first-in-class selective MDA5 agonist that functions as a dynamic molecular glue to enhance innate immune signaling. By targeting a plastic interface within MDA5 filaments, MA2 potentiates antiviral activity and synergizes with chemotherapy and natural killer cells to improve tumor cell killing.
In Depth

Key Findings

MA2 is a first-in-class selective MDA5 agonist that acts as a molecular glue to stimulate innate immunity. Unlike traditional modulators, MA2 does not induce the assembly of new filaments; instead, it potentiates pre-existing MDA5 filaments. This mechanism allows for context-dependent activation specifically in cells enriched with dsRNA. In practical applications, MA2 enhances antiviral activity and works synergistically with natural killer cells and chemotherapeutic agents to promote the killing of tumor cells.

Technical Details

The molecule targets a cryptic inter-protomer pocket within MDA5 filaments. This interface is characterized by conformational remodeling associated with ATPase activity. MA2 operates as a dynamic glue, meaning it remains bound to the interface while accommodating and reshaping structural transitions rather than locking the interface rigidly. This binding results in several biochemical effects:

  • Strengthening of inter-protomer interactions.
  • Strengthening of MDA5–dsRNA interactions.
  • Attenuation of ATP hydrolysis.

Background & Context

MDA5 is a cytosolic dsRNA sensor responsible for activating type I interferon signaling. This signaling pathway is described as a double-edged sword: while uncontrolled activation can lead to autoinflammatory diseases, controlled activation is essential for enhancing antitumor and antiviral immunity. Despite its importance, small-molecule modulators for MDA5 have previously remained elusive due to the nature of its interfaces.

Significance & Outlook

The discovery of MA2 demonstrates that dynamic molecular glues can be used to target conformationally plastic interfaces that were previously considered undruggable. By modulating the MDA5 filament interface to enhance protective immunity, this approach provides a potential strategy for developing new therapeutic interventions in oncology and virology.

Source: https://www.biorxiv.org/content/10.64898/2026.10.14.759171v1

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Published by Troy-Technical, an independent site run by one engineer with a career in materials development.
About the author / Contact info@troy-technical.jp
Let's share this post !

Author of this article

TOC